Vanguard Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.6M | Sell |
2,189,428
-89,232
| -4% | -$2.06M | ﹤0.01% | 2113 |
|
|
2025
Q1 | $61.5M | Buy |
2,278,660
+142,328
| +7% | +$3.84M | ﹤0.01% | 2006 |
|
|
2024
Q4 | $114M | Buy |
2,136,332
+288,402
| +16% | +$15.4M | ﹤0.01% | 1814 |
|
|
2024
Q3 | $84M | Buy |
1,847,930
+286,172
| +18% | +$13M | ﹤0.01% | 1951 |
|
|
2024
Q2 | $65.4M | Buy |
1,561,758
+203,798
| +15% | +$8.54M | ﹤0.01% | 2044 |
|
|
2024
Q1 | $51.1M | Buy |
1,357,960
+378,477
| +39% | +$14.2M | ﹤0.01% | 2158 |
|
|
2023
Q4 | $10.5M | Buy |
979,483
+37,202
| +4% | +$399K | ﹤0.01% | 2919 |
|
|
2023
Q3 | $9.5M | Buy |
942,281
+180,291
| +24% | +$1.82M | ﹤0.01% | 2918 |
|
|
2023
Q2 | $9.04M | Sell |
761,990
-10,665
| -1% | -$127K | ﹤0.01% | 3002 |
|
|
2023
Q1 | $9.35M | Buy |
772,655
+18,035
| +2% | +$218K | ﹤0.01% | 2973 |
|
|
2022
Q4 | $9.94M | Sell |
754,620
-5,854
| -0.8% | -$77.1K | ﹤0.01% | 2949 |
|
|
2022
Q3 | $10.3M | Buy |
760,474
+110,834
| +17% | +$1.5M | ﹤0.01% | 2940 |
|
|
2022
Q2 | $7.93M | Buy |
649,640
+83,661
| +15% | +$1.02M | ﹤0.01% | 3112 |
|
|
2022
Q1 | $8.12M | Buy |
565,979
+32,908
| +6% | +$472K | ﹤0.01% | 3264 |
|
|
2021
Q4 | $10.5M | Buy |
533,071
+2,829
| +0.5% | +$55.8K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $11.5M | Buy |
530,242
+501,266
| +1,730% | +$10.8M | ﹤0.01% | 3158 |
|
|
2021
Q2 | $723K | Buy |
+28,976
| New | +$723K | ﹤0.01% | 4207 |
|